iShares Neuroscience and ... (IBRN)
AMEX: IBRN
· Real-Time Price · USD
25.91
-0.00 (-0.00%)
At close: Sep 12, 2025, 9:46 AM
-0.00% (1D)
| Bid | 25.65 |
| Market Cap | 3.8M |
| AUM | 3.83M |
| NAV | 25.55 |
| EPS (ttm) | 1.39 |
| PE Ratio (ttm) | 18.65 |
| Shares Out | 146.66K |
| Inception Date | Aug 24, 2022 |
| Ask | 26.35 |
| Volume | 5 |
| Open | 25.57 |
| Previous Close | 25.91 |
| Day's Range | 25.57 - 25.91 |
| 52-Week Range | 17.86 - 28.74 |
| Holdings | 53 |
| Expense Ratio | 0.47% |
About IBRN
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Asset Class Equity
Ticker Symbol IBRN
Inception Date Aug 24, 2022
Provider Blackrock
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 41.20% of assets
| Name | Symbol | Weight |
|---|---|---|
| Supernus Pharmaceuti... | SUPN | 5.13% |
| Argenx Se | ARGX | 4.88% |
| Xenon Pharmaceutical... | XENE | 4.39% |
| Neurocrine Bioscienc... | NBIX | 4.21% |
| Ptc Therapeutics, In... | PTCT | 4.20% |
| Acadia Pharmaceutica... | ACAD | 4.05% |
| Biogen Inc. | BIIB | 4.01% |
| Denali Therapeutics ... | DNLI | 3.73% |
| Scholar Rock Holding... | SRRK | 3.42% |
| Alkermes Plc | ALKS | 3.18% |
Dividends Dividend Yield 0.39%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
